CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
Authors
Alan B. Sandler
Alexander Y. Popovich
+31 more
Amy J. Eisenfeld
Antoaneta Tomova
Blackhall
Borys T. Bilynsky˘ı
Bruce Bandstra
Centers for Disease Control and Prevention (CDC)
Ettinger
Fred B. Oldham
Gridelli
Hoffman
Igor N. Bondarenko
Ippolit Y. Kostinsky
Jack W. Singer
Janssen-Heijnen
Jemal
Kosmidis
Langer
Larissa Sandalic
Lilenbaum
Mark A. Socinski
Mary E.R. O'Brien
National Cancer Institute
Neubauer
Perrone
Pfister
Rothmann
Singer
Soria
Therasse
Valentin L. Ganul
Yevhen S. Hotko
Publication date
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 01/04/2019